Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126298342 | 12629834 | 2 | F | 20160520 | 20160921 | 20160808 | 20160928 | EXP | US-UCBSA-2016019579 | UCB | 33.49 | YR | F | Y | 57.00000 | KG | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126298342 | 12629834 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | 400 MG, EV 2 WEEKS(QOW) | Y | 125160 | 400 | MG | SOLUTION FOR INJECTION | QOW | ||||||
| 126298342 | 12629834 | 2 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | 200 MG, EV 2 WEEKS(QOW) | Y | 125160 | 200 | MG | SOLUTION FOR INJECTION | QOW | ||||||
| 126298342 | 12629834 | 3 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | 200 MG, EV 2 WEEKS(QOW) | Y | 125160 | 200 | MG | SOLUTION FOR INJECTION | QOW | ||||||
| 126298342 | 12629834 | 4 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 250/50 MG PRN | U | 0 | INHALER | |||||||||
| 126298342 | 12629834 | 5 | C | ALBUTEROL. | ALBUTEROL | 1 | Oral | 50-100 MG PRN | U | 0 | |||||||||
| 126298342 | 12629834 | 6 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | Oral | MG | U | 0 | |||||||||
| 126298342 | 12629834 | 7 | C | DERMABOND | OCRYLATE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126298342 | 12629834 | 1 | Ankylosing spondylitis |
| 126298342 | 12629834 | 4 | Asthma |
| 126298342 | 12629834 | 5 | Asthma |
| 126298342 | 12629834 | 6 | Migraine |
| 126298342 | 12629834 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126298342 | 12629834 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126298342 | 12629834 | Accident | |
| 126298342 | 12629834 | Condition aggravated | |
| 126298342 | 12629834 | Cough | |
| 126298342 | 12629834 | Injection site discolouration | |
| 126298342 | 12629834 | Lip injury | |
| 126298342 | 12629834 | Mouth injury | |
| 126298342 | 12629834 | Productive cough | |
| 126298342 | 12629834 | Pyrexia | |
| 126298342 | 12629834 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126298342 | 12629834 | 1 | 20160512 | 2016 | 0 | |
| 126298342 | 12629834 | 2 | 2016 | 2016 | 0 | |
| 126298342 | 12629834 | 3 | 201608 | 20160820 | 0 |